Success Metrics

Clinical Success Rate

60.0%

Based on 3 completed trials

Completion Rate

60%(3/5)

Active Trials

2(25%)

Results Posted

100%(3 trials)

Terminated

2(25%)

Phase Distribution

Ph phase_3

13%

Ph not_applicable

13%

Ph phase_2

38%

Ph phase_4

38%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution8 total trials

Phase 2Efficacy & side effects

3(37.5%)

Phase 3Large-scale testing

1(12.5%)

Phase 4Post-market surveillance

3(37.5%)

N/ANon-phased studies

1(12.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

60.0%

3 of 5 finished

Non-Completion Rate

40.0%

2 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(2)

Completed(3)

Terminated(2)

Other(1)

Detailed Status

Completed3

Terminated2

Recruiting2

unknown1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

60.0%

Most Advanced

Phase 4

Trials by Phase

Phase 23 (37.5%)

Phase 31 (12.5%)

Phase 43 (37.5%)

N/A1 (12.5%)

Trials by Status

completed338%

terminated225%

unknown113%

recruiting225%

Recent Activity

2 active trials

Showing 5 of 8

completedphase_2

Atherosclerosis, Immune Mediated Inflammation and Hypoestrogenemia in Young Women

NCT03018366

recruitingphase_4

Long Term Effects of Oral Versus Transdermal Estrogen Replacement Therapy in Turner Syndrome

NCT06570460

recruitingphase_4

Determining Dose Equivalence Between Oral and Transdermal Estrogen Treatment in Women With Turner Syndrome

NCT06544473

terminatedphase_4

Comparison of PKs of 17-Beta-Estradiol Via Sublingual Placement Versus Swallowing in Male-to-Female Transgender Patients

NCT05428215

terminatedphase_2

Clinical Trial of Estrogen for Postpartum Depression

NCT00059228

View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials

NCT03018366Phase 2

Atherosclerosis, Immune Mediated Inflammation and Hypoestrogenemia in Young Women

Completed

NCT06570460Phase 4

Long Term Effects of Oral Versus Transdermal Estrogen Replacement Therapy in Turner Syndrome

Recruiting

NCT06544473Phase 4

Determining Dose Equivalence Between Oral and Transdermal Estrogen Treatment in Women With Turner Syndrome

Recruiting

NCT05428215Phase 4

Comparison of PKs of 17-Beta-Estradiol Via Sublingual Placement Versus Swallowing in Male-to-Female Transgender Patients

Terminated

NCT00059228Phase 2

Clinical Trial of Estrogen for Postpartum Depression

Terminated

NCT01710696Phase 3

Induction of Puberty With 17-beta Estradiol in Girls With Turner Syndrome

Completed

NCT01023178Not Applicable

Comparison of Transdermal and Oral Estrogens in Adolescent Girls With Ovarian Failure

Completed

NCT02677259Phase 2

Luteal Phase Estradiol Support for In Vitro Fertilization/Intracytoplasmic Sperm Injection Cycles

Unknown

All 8 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 8